Novel roles of karyopherin subunit alpha 2 in hepatocellular carcinoma

• Published in: Biomedicine & pharmacotherapy 2023-07, Vol.163, p.114792-114792, Article 114792
• Main Authors: Yang, Xingyue, Wang, Hu, Zhang, Li, Yao, Shun, Dai, Jing, Wen, Guorong, An, Jiaxing, Jin, Hai, Du, Qian, Hu, Yanxia, Zheng, Liming, Chen, Xingyue, Yi, Zhiqiang, Tuo, Biguang
• Format: Article
• Language: English
• Subjects: Active Transport, Cell Nucleus; AKT signaling pathways; alpha Karyopherins - genetics; alpha Karyopherins - metabolism; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - pathology; Humans; Karyopherin subunit alpha 2; Karyopherins - metabolism; Liver Neoplasms - genetics; Liver Neoplasms - pathology; MiRNAs; P53
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.114792

Hepatocellular carcinoma is the most common type of liver cancer and associated with a high fatality rate. This disease poses a major threat to human health worldwide. A considerable number of genetic and epigenetic factors are involved in the development of hepatocellular carcinoma. However, the molecular mechanism underlying the progression of hepatocellular carcinoma remains unclear. Karyopherin subunit alpha 2 (KPNA2), also termed importin α1, is a member of the nuclear transporter family. In recent years, KPNA2 has been gradually linked to the nuclear transport pathway for a variety of tumor-associated proteins. Furthermore, it promotes tumor development by participating in various pathophysiological processes such as cell proliferation, apoptosis, immune response, and viral infection. In hepatocellular carcinoma, it has been found that KPNA2 expression is significantly higher in liver cancer tissues versus paracancerous tissues. Moreover, it has been identified as a marker of poor prognosis and early recurrence in patients with hepatocellular carcinoma. Nevertheless, the role of KPNA2 in the development of hepatocellular carcinoma remains to be determined. This review summarizes the current knowledge on the pathogenesis and role of KPNA2 in hepatocellular carcinoma, and provides new directions and strategies for the diagnosis, treatment, and prediction of prognosis of this disease.